Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

ClinicalTrials.gov ID: NCT00870584

Public ClinicalTrials.gov record NCT00870584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26-week Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the effect of omalizumab on markers of impairment in patients with inadequately controlled persistent allergic asthma on Step 4 or above therapy as defined in the 2007 National Heart, Lung, and Blood Institute (NHBLI) Guidelines

Study identification

NCT ID
NCT00870584
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
271 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2009 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Nov 17, 2011

2009 – 2010

United States locations

U.S. sites
50
U.S. states
27
U.S. cities
49
Facility City State ZIP Site status
Jasper Summit Research, LLC Jasper Alabama 35501 —
Allergy Asthma and Immunology Center of Alaska Anchorage Alaska 99508 —
Medical Research of Arizona, A division of Allergy Asthma & Immunology Associates, LTD Scottsdale Arizona 85251 —
Waren W. Pleskow, MD Encinitas California 92024 —
William Ebbeling, MD, Inc Fresno California 93720 —
Pediatric Care Medical Group, Inc Huntington Beach California 92647 —
California Allergy & Asthma Medical Group Palmdale California 93551 —
Allergy Associates Medical Group, Inc San Diego California 92120 —
Sansum Clinic Santa Barbara California 93110 —
Allergy & Asthma Clinical Research, Inc. Walnut Creek California 94598 —
Innovative Research of West Florida, Inc Clearwater Florida 33756 —
Palm Spring Research Institute, Inc Hialeah Florida 33012 —
Integrity Research, LLC Pensacola Florida 32514 —
Hugh Windom, MD, PA Sarasota Florida 34233 —
South Miami Clinical Research, LLC South Miami Florida 33143 —
Georgia Pollens Clinical Research Centers, Inc Albany Georgia 31707 —
Sneeze, Wheeze and Itch Associates, LLC Normal Illinois 61761 —
Chest Medicine Clinical Services Skokie Illinois 60076 —
Clinical Research Center of Indiana Indianapolis Indiana 46208 —
Kansas City Allergy & Asthma Center Overland Park Kansas 66210 —
Cotton-O'Neil Clinical Research Center Topeka Kansas 66606 —
Abraham Research, PLLC Crescent Springs Kentucky 41017 —
Rx R&D Metairie Louisiana 70002 —
Acadiana Medicine Clinic Opelousas Louisiana 70570 —
Paul A Shapero, MD Bangor Maine 04401 —
Chesapeake Clinical Research Baltimore Maryland 21236 —
Respiratory Medicine Research Institute of Michigan Ypsilanti Michigan 48197 —
Clinical Research Institute Minneapolis Minnesota 55402 —
The Clinical Research Center, LLC St Louis Missouri 63141 —
Montana Medical Research, Inc. Missoula Montana 59808 —
Maimonides Medical Center, Division of Pediatric Pulmonology Brooklyn New York 11219 —
Allergy Asthma Immunology of Rochester Research Center Rochester New York 14618 —
Alan Kaufman, MD The Bronx New York 10465 —
Allergy & Asthma Center of NC, PA High Point North Carolina 27262 —
Wilmington Medical Research Wilmington North Carolina 28401 —
Allergy and Respiratory Center Canton Ohio 44718 —
New Horizons Clinical Research Cincinnati Ohio 45242 —
Oklahoma Allergy & Asthma Clinic Oklahoma City Oklahoma 73104 —
Allergy, Asthma and Clinical Research Center Oklahoma City Oklahoma 73120 —
Baker Allergy Asthma and Dermatology Research Center, LLC Lake Oswego Oregon 97035 —
Asthma Allergy & Pulmonary Associates Philadelphia Pennsylvania 19107 —
AAPRI Clinical Research Institute Lincoln Rhode Island 02865 —
Pediatric Pulmonary Associates of North Texas, PA Dallas Texas 75230 —
Western Sky Medical Research El Paso Texas 79903 —
North Texas Institute for Clinical Trials Fort Worth Texas 76132 —
Allergy & Asthma Associates Houston Texas 77054 —
Lynchburg Pulmonary Associates Lynchburg Virginia 24501 —
Virginia Adult and Pediatric Allergy and Asthma PC Richmond Virginia 23229 —
Asthma Inc. Seattle Washington 98105 —
Pulmonary and Research Associates Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00870584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2011 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00870584 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →